Therefore, STAT3 provides an exceptional molecular target at the key node of the immune system network, based on the antigen-presenting potential of DCs/macrophages or complex tumor-promoting activity of TAMs and MDSCs. The gene discussed is STAT3; the disease is neoplasm.